Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of TQZ2451 vs Victoza in Type 2 Diabetes
NCT04373967Phase 3Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Apr 2020
- Primary completion
- Dec 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of Liraglutide (Chia Tai Tianqing) in type 2 diabetes mellitus (T2DM), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04373967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04373967.